Rick Pauls
2019
In 2019, Rick Pauls earned a total compensation of $1.5M as President and Chief Executive Officer at DiaMedica Therapeutics, a 105% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,000 |
|---|---|
| Option Awards | $890,736 |
| Salary | $420,000 |
| Other | $14,650 |
| Total | $1,503,386 |
Pauls received $890.7K in option awards, accounting for 59% of the total pay in 2019.
Pauls also received $178K in non-equity incentive plan, $420K in salary and $14.7K in other compensation.
Rankings
In 2019, Rick Pauls' compensation ranked 7,313th out of 13,971 executives tracked by ExecPay. In other words, Pauls earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,313 out of 13,971 | 48th |
Division Manufacturing | 2,817 out of 5,701 | 51st |
Major group Chemicals And Allied Products | 1,052 out of 2,200 | 52nd |
Industry group Drugs | 895 out of 1,886 | 53rd |
Industry Pharmaceutical Preparations | 664 out of 1,398 | 53rd |
Source: SEC filing on April 20, 2020.
Pauls' colleagues
We found two more compensation records of executives who worked with Rick Pauls at DiaMedica Therapeutics in 2019.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019